CAR T-Cell Therapy for Mesothelioma in New Phase I Trial
Researchers at Memorial Sloan Kettering in New York are about to try a new kind of CAR T-cell therapy for…
Study to Test Nivolumab and Chemotherapy for Mesothelioma
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients who have had…
Asbestos | Asia | Immune Systems | International | Research
Asbestos Affects Immunity, New Report Finds
A new report from Japanese doctors shows that asbestos affects immunity. It may help explain why exposure to asbestos can…
Manipulating “Fight or Flight” Could Impact Effectiveness of Immunotherapy for Mesothelioma
Doctors at the University of Connecticut may have found a way to influence the effectiveness of immunotherapy by manipulating the…
T-Cell Immunotherapy Trial Could be Good News for Mesothelioma Patients
The first four mesothelioma patients treated with a new kind of T-cell immunotherapy have responded well with few side effects. …
Non-Epithelioid Mesothelioma: Immunotherapy Combo Could be the New Standard of Care
Two immunotherapy drugs could become the new standard of care for people with non-epithelioid mesothelioma. All forms of malignant mesothelioma…
Immunotherapy with Durvalumab: Record Survival in Inoperable Mesothelioma
There is new evidence that the immunotherapy drug durvalumab may make chemotherapy more effective for people with inoperable pleural mesothelioma.…
Infections Can Help Fight Mesothelioma, Study Suggests
There is new evidence to support the idea that infections can help fight mesothelioma. Researchers at a Belgium University say…
Photoimmunotherapy for Mesothelioma Reduces Tumor Volume in Mice
Japanese researchers testing photoimmunotherapy for mesothelioma say they used the technology to successfully reduce the size of tumors in mice.…
Social Distancing for Mesothelioma Patients: Unexpected Upside?
As concern about the novel coronavirus spreads around the world, there could be an unexpected upside to social distancing for…